3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Immunoglobulin Light-chain Amyloidosis
3
Pleural Effusion, Malignant
2
Amyloidosis
2
Tuberous Sclerosis
1
Skin Toxicity
1
Ras-wildtype Colorectal Cancer
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Menstruation Disturbances
1
Lymphoma, Non-Hodgkin
1
Lymphangioleiomyomatosis
1
Intracranial Aneurysm
1
Hyperandrogenism
1
Hemangioma, Cavernous
1
Head and Neck Neoplasms
1
Exanthema
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Arteriovenous Malformations
1
Amyloidosis, Familial
1
Advanced Malignant Neoplasm
1
AA amyloidosis
1
Interventions
Metformin
91
Clomiphene
31
Letrozole
23
Inositol
19
Folic Acid
11
Chorionic Gonadotropin
11
Exercise
10
High-Intensity Interval Training
9
drospirenone and ethinyl estradiol combination
8
Ethinyl Estradiol
8
Contraceptives, Oral
8
Cholecalciferol
8
cetrorelix
7
Tablets
7
Progesterone
7
Menotropins
6
follitropin alfa
5
Pioglitazone
5
Liraglutide
5
Exenatide
5
Cyproterone Acetate
5
Caloric Restriction
5
Vitamin D
4
Triptorelin Pamoate
4
Surveys and Questionnaires
4
Sugars
4
Spironolactone
4
Glycoprotein Hormones, alpha Subunit
4
Fish Oils
4
Estradiol
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Polycystic Ovary Syndrome
×
Doxycycline
×
Clear all
NCT01788215
2016-01-13
MI-PCOS
University of Rochester
Phase 3
Completed
10 enrolled
14 charts